Table 1.
Patient characteristics.
Fig 1.
Distribution of CHA2DS2-VASc and HAS-BLED scores.
# Labile international normalised ratio is also a component of the HAS-BLED score but was not included as there is incomplete recording in IMS® Disease Analyzer. The HAS-BLED score therefore ranges from 0 to 8. High alcohol intake has been included in the HAS-BLED score however is likely under-recorded in IMS® Disease Analyzer.
Fig 2.
History of stroke risk factors and bleeding events.
TIA = transient ischaemic attack; GI = gastrointestinal.
Fig 3.
Cumulative incidence of OAC non-persistence.
Table 2.
Cumulative incidence of persistence rates at specified time points.
Table 3.
Comparison of non-persistence overall and using a time-partitioned approach in final, adjusted model.
Fig 4.
Cumulative incidence of OAC non-persistence in sensitivity analyses (A) using a discontinuation gap of 30 days and (B) when INR records are not used to estimate VKA treatment.